Staff Software Engineer (Inference Platform), London
Isomorphic Labs4 hours ago
London, United KingdomStaff+
Responsibilities
- Develop and operate an inference platform serving fleets of machine learning models to scientific applications.
- Set platform strategy and build roadmaps for platform maturity.
- Architect and optimize inference services to address scaling limits, maximize throughput, and maintain feature parity across the model-serving stack.
- Make technical decisions about tooling and architecture while partnering with science, product, operations, research, and applied ML teams.
- Deliver high-quality, well-tested, user-focused software features.
- Lead efforts to harden systems for reliability, scalability, larger datasets, and larger models.
Requirements
- Proven experience architecting and managing large-scale AI/ML workloads in production.
- Significant experience deploying and managing complex workloads within Kubernetes, specifically GKE.
- Expertise in cloud compute design using Google Cloud Platform.
- Professional familiarity with NVIDIA GPU generations and high-performance computing.
- Strong programming skills and a reliability-first approach to software development.
- Preferred: experience spanning ML Software Engineering and Infrastructure SRE roles.
- Preferred: experience leading multidisciplinary projects and managing complex stakeholder requirements.
- Preferred: familiarity with workload scheduling, ML efficiency research, hardware benchmarking, Google TPU generations, and specialized ML-driven R&D cycles.
Benefits
- Hybrid working model requiring attendance in the London office three days per week, currently Tuesday, Wednesday, and one additional team-dependent day.
- Equal employment opportunity and reasonable accommodation support are provided.
Tech Stack
Categories
About Isomorphic Labs
Isomorphic Labs develops AI models and a computational drug design platform for pharmaceutical R&D, working primarily through discovery collaborations and licensing. Founded in 2021 by Alphabet and headquartered in London, the company builds on advances such as AlphaFold to predict and design novel molecules. It has announced multi-year partnerships with Eli Lilly and Novartis to apply its technology to new therapeutics.